Cyteir Therapeutics (CYTT) Stock Chart & Stock Price History → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free CYTT Stock Alerts $3.01 -0.01 (-0.33%) (As of 03/18/2024) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsSEC FilingsSocial MediaStock AnalysisChartEarningsFinancialsSEC FilingsSocial Media Cyteir Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance0.00% Receive CYTT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyteir Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. CYTT Stock Chart for Sunday, May, 19, 2024 CYTT Chart by TradingView Cyteir Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/16/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/15/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/14/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/13/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/10/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million Get the Latest News and Ratings for CYTT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyteir Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/08/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/07/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/06/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/03/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/02/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million05/01/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/30/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/29/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/26/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/25/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/24/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/23/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/22/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/19/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/18/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/17/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/16/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/15/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/12/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/11/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/10/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/09/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/08/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/05/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/04/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/03/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/02/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million04/01/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/29/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/28/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/27/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/26/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/25/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond03/22/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/21/2024$3.01$3.01$3.19$2.92551,300 shs$108.36 million03/20/2024N/A$3.01$3.19$2.92551,300 shs$108.36 million Related Companies: Allakos Stock Price Chart Citius Pharmaceuticals Stock Price Chart Cue Biopharma Stock Price Chart Assertio Stock Price Chart PMV Pharmaceuticals Stock Price Chart Genelux Stock Price Chart Relmada Therapeutics Stock Price Chart IO Biotech Stock Price Chart Rezolute Stock Price Chart OptiNose Stock Price Chart Receive CYTT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyteir Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYTT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyteir Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
